Skip to main content

AMERIPRISE FINANCIAL INC

Position in ABVX — Abivax S.A.

CIK 820027 MINNEAPOLIS, MN

Position in ABVX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$17,299,279
+$8,053,779 QoQ
Shares Held
129,816
+56.3% QoQ
Ownership
0.149%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 302 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ABVX Over Time

Shares Held

Position Value (USD)

Derivatives in ABVX

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$2,438,658
PutShares
18,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AMERIPRISE FINANCIAL INC holds $5,025,615,702 across 202 Biotechnology names. ABVX ranks #43 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ABVX

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,438,658 18,300
2026-06-30 $17,299,279 129,816
2026-03-31 $9,245,500 83,031
2025-12-31 $9,124,962 67,665
2025-09-30 $4,976,668 58,618
2025-03-31 $118,750 19,000
2024-12-31 $85,409 11,668